Memantine or Riluzole Prophylaxis for Corticosteroid-induced Mood and Declarative Memory Changes
Status:
Terminated
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The primary purpose is to determine if patients scheduled to receive prescription
corticosteroid therapy for inflammatory illnesses who are given either memantine or riluzole
pretreatment will show lesser declarative memory impairment than those receiving placebo.
The exploratory purpose is to determine if patients scheduled to receive prescription
corticosteroid therapy for inflammatory illnesses who are given memantine or riluzole
pretreatment will show a smaller increase in manic/hypomanic symptom severity than those
receiving placebo.